Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision label Revision: v3.5.4 was added and an older label Revision: v3.5.3 was removed, indicating a small version update to the page's text. This update appears to be a release-note style change rather than a modification to study details.
    Difference
    0.0%
    Check dated 2026-05-15T03:59:26.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content. This change is a metadata-level patch rather than a substantive update to the study information.
    Difference
    0.0%
    Check dated 2026-04-30T18:28:11.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:24:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:02:46.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a system-level update with no visible changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-03-11T16:56:06.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    An administrative revision tag (v3.4.2) was added and previously displayed notices about government funding and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:04:17.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.